When was Alterity Therapeutics Limited stock made available for the first time to the public?

The IPO Date for Alterity Therapeutics Limited is 2003-09-29. On this 2003-09-29, Alterity Therapeutics Limited stock was made publicly available.

Where is the headquarters of Alterity Therapeutics Limited stock?

Headquarters of Alterity Therapeutics Limited is in AU at 460 Bourke Street, Melbourne, VIC 3000.

What industry does Alterity Therapeutics Limited belong to?

The Alterity Therapeutics Limited belongs to Biotechnology.

Alterity Therapeutics Limited

ATHE•NASDAQ

Healthcare

Biotechnology

$4.59

$0.70(17.99%)

Alterity Therapeutics Limited (ATHE) Company Profile & Overview

Explore Alterity Therapeutics Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Alterity Therapeutics Limited (ATHE) Company Profile & Overview

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

SectorHealthcare

IndustryBiotechnology

CEODavid A. Stamler

Contact Information

https://alteritytherapeutics.com

61 3 9349 4906

460 Bourke Street, Melbourne, VIC, 3000

Company Facts

10 Employees

IPO DateSep 29, 2003

CountryAU

Actively Trading

Frequently Asked Questions

;